Insider Trading & Ownership - Hatfield Jeffrey S.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hatfield Jeffrey S.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-22
Option Award
2023-05-24
2:34 pm
2024-05-22
2033-05-21
Vir Biotechnology Inc.VIRHatfield Jeffrey S.
Director
18,081$027,860
(Direct)
View
2022-05-23
Option Award
2022-05-25
5:51 pm
2023-05-23
2032-05-22
Vir Biotechnology Inc.VIRHatfield Jeffrey S.
Director
19,215$022,589
(Direct)
View
2021-05-21
Option Award
2021-05-25
4:35 pm
2022-05-21
2031-05-20
Vir Biotechnology Inc.VIRHatfield Jeffrey S.
Director
10,122$010,122
(Direct)
View
2021-02-04
Option Award
2021-02-08
5:40 pm
N/A
2031-02-04
Viridian Therapeutics Inc.VRDNHatfield Jeffrey S.
Director
25,000$025,000
(Direct)
View
2020-12-09
Option Award
2020-12-11
4:42 pm
N/A
2030-12-08
Vir Biotechnology Inc.VIRHatfield Jeffrey S.
Director
46,500$046,500
(Direct)
View
2020-05-21
Option Award
2020-05-22
5:35 pm
N/A
2030-05-20
MIRAGEN THERAPEUTICS INC.MGENHatfield Jeffrey S.
Director
24,000$024,000
(Direct)
View
2020-05-06
Option Award
2020-05-08
5:02 pm
N/A
2030-05-06
aTYR PHARMA INCLIFEHatfield Jeffrey S.
Director
1,428$01,428
(Direct)
View
2019-06-19
Option Award
2019-06-21
5:14 pm
N/A
2029-06-18
MIRAGEN THERAPEUTICS INC.MGENHatfield Jeffrey S.
Director
12,000$012,000
(Direct)
View
2019-05-08
Option Award
2019-05-10
5:22 pm
N/A
2029-05-08
aTYR PHARMA INCLIFEHatfield Jeffrey S.
Director
20,000$020,000
(Direct)
View